Advances in central serous chorioretinopathy: from diagnosis to treatment

AbstractPurpose To discuss the role of indocyanine green angiography (ICGA) in central serous chorioretinopathy (CSC)Methods Review of the current literature and the experience of a tertiary referral centre is reported.Results ICGA is an essential method used to diagnose, treat and follow patient affected by central serous chorioretinopathy. This technique enabled ophthalmologists to have more insight in the pathogenesis of CSC. Recently the utility of ICGA in CSC has been re‐discussed again in relation to the different patterns of choroidal permeability, distribution of the fluid and the reponse to photodynami therapy. We will discuss the state of the art of clinical use and the evidences in the medical literature of the ICGA.Conclusion ICGA is an validated method for the evaluation of CSC, which can provide essential informations for the clinical assessment and management of this disease. The evidences suggest its use in every case of CSC in order to make diagnosis and guide photodynamic therapy.